Home > > > Global Brugada Syndrome Industry Expands at 7.8% CAGR with Contributions from Biotronik, MicroPort S

Global Brugada Syndrome Industry Expands at 7.8% CAGR with Contributions from Biotronik, MicroPort S

Author : kaustubh Ravan | Published On : 30 Apr 2026

The global Brugada Syndrome market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.8 billion by the end of 2034, growing at a CAGR of 7.8% from 2024 to 2034. Market growth is driven by increasing awareness of rare cardiac disorders, advancements in diagnostic technologies, and rising adoption of implantable cardioverter defibrillators (ICDs) and genetic testing for early detection and management.

Brugada syndrome is referred to as a rare but potentially fatal heart rhythm condition (arrhythmia) that is, at times, inherited. The individuals contracting Brugada syndrome are at an increased risk of irregular heart rhythms starting with lower chambers of heart (ventricles).

Dive Deeper into Data: Get Your In-Depth Sample Now! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86108

Treatment pertaining to Brugada syndrome constitutes preventive measures such as reduction of fever and aversion of medications triggering arrhythmia. Certain individuals suffering from Brugada syndrome require an implantable cardioverter-defibrillator (ICD).

Key Findings of the Market Report

  • Type 1 Brugada Syndrome is the dominant disease segment, accounting for 53.8% of the market in 2026 due to its definitive ECG pattern and higher clinical risk.
  • Resting ECG remains the foundational diagnostic modality, expected to hold a 35.8% share of the diagnostic segment in 2026.
  • Hospitals are the primary end-users, while Specialty Cardiac Centers are seeing a rise in high-density mapping and ablation procedures.
  • Pharmacological Therapy (e.g., Quinidine) serves as a vital segment for pediatric patients and those ineligible for ICDs, though it remains a smaller revenue contributor compared to devices.

Global Market: Growth Drivers

  • Increased Prevalence and Awareness: Enhanced recognition of Sudden Cardiac Death (SCD) risks in young adults is driving screening volume.
  • Genetic Testing Advancements: Integration of NGS (Next-Generation Sequencing) allows for precise family-wide risk stratification.
  • Technological Shifts in EP: Mapping-guided ablation techniques are becoming a standard "second-line" treatment for high-risk cases.
  • Urbanization in Asia: Improved clinical infrastructure in Southeast Asia is unmasking a massive previously undiagnosed patient population.

Global Market: Key Players

The competitive landscape is dominated by medical device titans that provide the high-end sensing and defibrillation hardware necessary for chronic management.

  • Medtronic
  • Boston Scientific Corporation
  • Abbott (St. Jude Medical)
  • LivaNova PLC
  • Novartis AG (Pharmacological interventions)
  • Edwards Lifesciences Corporation
  • GE Healthcare (Diagnostic imaging/ECG)
  • Sun Pharmaceutical Industries Ltd.
  • GeneDx (Genetic testing specialists)
  • PGxHealth LLC

Global Market: Segmentation

By Product Type

  • Implantable Cardioverter-Defibrillators (ICDs) - Market Leader
  • Pharmacological Therapy (Quinidine, Isoproterenol)
  • Catheter Ablation Equipment
  • Genetic Testing Kits & AI-ECG Software

By Diagnosis Type

  • Electrocardiogram (ECG) - Standard Modality
  • Electrophysiology Study (EPS)
  • Provocation Testing (Sodium Channel Blocker Challenge)
  • Genetic Testing

By End-User

  • Tertiary Care Hospitals
  • Specialty Cardiac Centers
  • Diagnostic & Genetic Laboratories
  • Academic & Research Institutes

Buy this Premium Research Report:  https://www.transparencymarketresearch.com/checkout.php?rep_id=86108&ltype=S

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com 
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com